Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$36.71 - $44.15 $79,954 - $96,158
-2,178 Reduced 4.23%
49,276 $2.05 Million
Q1 2023

May 08, 2023

BUY
$36.81 - $48.12 $13,840 - $18,093
376 Added 0.74%
51,454 $2.13 Million
Q4 2022

Feb 14, 2023

SELL
$35.68 - $44.71 $180,076 - $225,651
-5,047 Reduced 8.99%
51,078 $2.11 Million
Q3 2022

Nov 07, 2022

SELL
$42.51 - $54.02 $8.56 Million - $10.9 Million
-201,363 Reduced 78.2%
56,125 $2.46 Million
Q2 2022

Aug 10, 2022

BUY
$46.84 - $59.75 $9.37 Million - $12 Million
200,056 Added 348.34%
257,488 $12.7 Million
Q1 2022

May 12, 2022

BUY
$48.09 - $57.79 $20,101 - $24,156
418 Added 0.73%
57,432 $3.26 Million
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $1.49 Million - $1.97 Million
-31,509 Reduced 35.59%
57,014 $2.97 Million
Q3 2021

Nov 10, 2021

SELL
$56.91 - $67.81 $2.86 Million - $3.4 Million
-50,199 Reduced 36.19%
88,523 $5.3 Million
Q2 2021

Aug 11, 2021

SELL
$64.02 - $71.72 $277,334 - $310,691
-4,332 Reduced 3.03%
138,722 $9.4 Million
Q1 2021

May 14, 2021

BUY
$53.26 - $68.08 $41,542 - $53,102
780 Added 0.55%
143,054 $9.25 Million
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $5.18 Million - $6.74 Million
-119,225 Reduced 45.59%
142,274 $8.01 Million
Q3 2020

Nov 12, 2020

SELL
$47.43 - $60.75 $18.4 Million - $23.6 Million
-388,091 Reduced 59.74%
261,499 $12.4 Million
Q2 2020

Aug 12, 2020

SELL
$43.51 - $66.59 $640,380 - $980,071
-14,718 Reduced 2.22%
649,590 $35.3 Million
Q1 2020

May 11, 2020

SELL
$32.82 - $81.13 $2.37 Million - $5.86 Million
-72,241 Reduced 9.81%
664,308 $33.7 Million
Q4 2019

Feb 07, 2020

SELL
$60.96 - $77.7 $2.24 Million - $2.85 Million
-36,722 Reduced 4.75%
736,549 $57 Million
Q3 2019

Nov 04, 2019

BUY
$55.78 - $68.08 $11.4 Million - $14 Million
205,052 Added 36.09%
773,271 $49 Million
Q2 2019

Aug 05, 2019

SELL
$53.69 - $65.47 $5.9 Million - $7.19 Million
-109,883 Reduced 16.2%
568,219 $33.3 Million
Q1 2019

May 01, 2019

SELL
$44.53 - $58.9 $28.5 Million - $37.8 Million
-641,122 Reduced 48.6%
678,102 $38.5 Million
Q4 2018

Feb 11, 2019

SELL
$47.64 - $71.26 $3.65 Million - $5.47 Million
-76,716 Reduced 5.5%
1,319,224 $65.4 Million
Q3 2018

Nov 08, 2018

BUY
$52.03 - $71.41 $6.66 Million - $9.14 Million
127,979 Added 10.09%
1,395,940 $99.1 Million
Q2 2018

Aug 07, 2018

BUY
$48.15 - $56.68 $6.93 Million - $8.16 Million
143,926 Added 12.8%
1,267,961 $66.1 Million
Q1 2018

May 09, 2018

SELL
$46.03 - $61.28 $502,417 - $668,871
-10,915 Reduced 0.96%
1,124,035 $58.7 Million
Q4 2017

Feb 09, 2018

BUY
$50.58 - $60.79 $181,329 - $217,932
3,585 Added 0.32%
1,134,950 $65.5 Million
Q3 2017

Nov 09, 2017

BUY
$53.54 - $68.0 $60.6 Million - $76.9 Million
1,131,365
1,131,365 $61.6 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.